Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin

NCT04536805 is registered in ClinicalTrials.gov with Institut Cancerologie de l'Ouest as lead sponsor.

NCT NCT04536805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin
Lead sponsor
Institut Cancerologie de l'Ouest
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 17, 2020
Completion date
November 30, 2031
Enrollment
44 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer